Transcriptional Effects of Candidate COVID-19 Treatments on Cardiac Myocytes

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Jun 10

PMID 35686037

Authors

Tobias Jakobi

Julia Gross

Lukas Cyganek

Shirin Doroudgar

Affiliations

Soon will be listed here.

Abstract

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has emerged as a major cause of morbidity and mortality worldwide, placing unprecedented pressure on healthcare. Cardiomyopathy is described in patients with severe COVID-19 and increasing evidence suggests that cardiovascular involvement portends a high mortality. To facilitate fast development of antiviral interventions, drugs initially developed to treat other diseases are currently being repurposed as COVID-19 treatments. While it has been shown that SARS-CoV-2 invades cells through the angiotensin-converting enzyme 2 receptor (ACE2), the effect of drugs currently repurposed to treat COVID-19 on the heart requires further investigation.

Methods: Human induced pluripotent stem cell-derived cardiac myocytes (hiPSC-CMs) were treated with five repurposed drugs (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir/interferon beta (INF-β), hydroxychloroquine, and chloroquine) and compared with DMSO controls. Transcriptional profiling was performed to identify global changes in gene expression programs.

Results: RNA sequencing of hiPSC-CMs revealed significant changes in gene programs related to calcium handling and the endoplasmic reticulum stress response, most prominently for lopinavir/ritonavir and lopinavir/ritonavir/interferon-beta. The results of the differential gene expression analysis are available for interactive access at https://covid19drugs.jakobilab.org.

Conclusion: Transcriptional profiling in hiPSC-CMs treated with COVID-19 drugs identified unfavorable changes with lopinavir/ritonavir and lopinavir/ritonavir/INF-β in key cardiac gene programs that may negatively affect heart function.

References

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Cao Y, Deng Q, Dai S . Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel Med Infect Dis. 2020; 35:101647. PMC: 7151266. DOI: 10.1016/j.tmaid.2020.101647. View

Rossler U, Hennig A, Stelzer N, Bose S, Kopp J, Soe K . Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis. J Bone Miner Res. 2021; 36(8):1621-1635. DOI: 10.1002/jbmr.4322. View

Fernandez-Patron C, Filep J . GPCRs in cardiovascular pathologies. Drug Discov Today Dis Mech. 2014; 9(3):e75-e78. PMC: 4071045. DOI: 10.1016/j.ddmod.2012.07.001. View

Zinellu A, Paliogiannis P, Fois A, Solidoro P, Carru C, Mangoni A . Cholesterol and Triglyceride Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression. Front Public Health. 2021; 9:705916. PMC: 8417431. DOI: 10.3389/fpubh.2021.705916. View

Liao Y, Smyth G, Shi W . The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013; 41(10):e108. PMC: 3664803. DOI: 10.1093/nar/gkt214. View

Aggarwal G, Henry B, Aggarwal S, Bangalore S . Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019. Am J Cardiol. 2020; 128:147-150. PMC: 7228893. DOI: 10.1016/j.amjcard.2020.04.054. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

de Wilde A, Jochmans D, Posthuma C, Zevenhoven-Dobbe J, van Nieuwkoop S, Bestebroer T . Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014; 58(8):4875-84. PMC: 4136071. DOI: 10.1128/AAC.03011-14. View

10.

van Iersel M, Kelder T, Pico A, Hanspers K, Coort S, Conklin B . Presenting and exploring biological pathways with PathVisio. BMC Bioinformatics. 2008; 9:399. PMC: 2569944. DOI: 10.1186/1471-2105-9-399. View

11.

Omidi F, Hajikhani B, Kazemi S, Tajbakhsh A, Riazi S, Mirsaeidi M . COVID-19 and Cardiomyopathy: A Systematic Review. Front Cardiovasc Med. 2021; 8:695206. PMC: 8248804. DOI: 10.3389/fcvm.2021.695206. View

12.

Taura M, Kariya R, Kudo E, Goto H, Iwawaki T, Amano M . Comparative analysis of ER stress response into HIV protease inhibitors: lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway. Free Radic Biol Med. 2013; 65:778-788. DOI: 10.1016/j.freeradbiomed.2013.08.161. View

13.

Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T . Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 2012; 12(1):127-37. DOI: 10.1016/j.stem.2012.09.013. View

14.

Puntmann V, Carerj M, Wieters I, Fahim M, Arendt C, Hoffmann J . Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11):1265-1273. PMC: 7385689. DOI: 10.1001/jamacardio.2020.3557. View

15.

He B . Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 2006; 13(3):393-403. DOI: 10.1038/sj.cdd.4401833. View

16.

Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P . In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020; 71(15):732-739. PMC: 7108130. DOI: 10.1093/cid/ciaa237. View

17.

Bibbins-Domingo K, C Grossman D, Curry S, Davidson K, Epling Jr J, Garcia F . Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 316(19):1997-2007. DOI: 10.1001/jama.2016.15450. View

18.

Chan J, Yao Y, Yeung M, Deng W, Bao L, Jia L . Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis. 2015; 212(12):1904-13. PMC: 7107395. DOI: 10.1093/infdis/jiv392. View

19.

Doroudgar S, Glembotski C . New concepts of endoplasmic reticulum function in the heart: programmed to conserve. J Mol Cell Cardiol. 2012; 55:85-91. PMC: 3557761. DOI: 10.1016/j.yjmcc.2012.10.006. View

20.

McCHESNEY E . Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med. 1983; 75(1A):11-8. DOI: 10.1016/0002-9343(83)91265-2. View